Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02605616
What this trial is testing

Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
University of Alabama at Birmingham 93
Early research (Phase 1)Study completedNCT01232049
What this trial is testing

Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

Who this might be right for
Healthy
Asan Medical Center 24
Not applicableStudy completedNCT04597905
What this trial is testing

Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe

Who this might be right for
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases
Takeda 686
Early research (Phase 1)Study completedNCT07253753
What this trial is testing

Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation

Who this might be right for
Healthy
Yellowbird Diagnostics Inc 12
Large-scale testing (Phase 3)Study completedNCT01456195
What this trial is testing

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 421
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Post-approval studies (Phase 4)UnknownNCT02588937
What this trial is testing

Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Chong Kun Dang Pharmaceutical 76
Early research (Phase 1)Ended earlyNCT06254495
What this trial is testing

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more
Seagen, a wholly owned subsidiary of Pfizer 58
Testing effectiveness (Phase 2)Study completedNCT05228470
What this trial is testing

Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Who this might be right for
ElranatamabMyelomaMultiple Myeloma+8 more
Pfizer 39
Not applicableStudy completedNCT00314275
What this trial is testing

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 43
Not applicableEnded earlyNCT02668705
What this trial is testing

Agent-Enhanced Document Explanation

Who this might be right for
Mental Competency
Boston Medical Center 101
Large-scale testing (Phase 3)Study completedNCT00497237
What this trial is testing

Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 382
Testing effectiveness (Phase 2)Ended earlyNCT06029595
What this trial is testing

Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Who this might be right for
Uncontrolled Asthma
Chiesi Farmaceutici S.p.A. 517
Not applicableStudy completedNCT02413957
What this trial is testing

Medication Reconciliation in Comparison to an Extensive Medication Safety Check

Who this might be right for
ElderlyAdverse Drug Event
RWTH Aachen University 220
Early research (Phase 1)Study completedNCT07308041
What this trial is testing

Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin

Who this might be right for
Drug InteractionGERD (Gastroesophageal Reflux Disease)Safety, and Tolerability
Cinclus Pharma Holding AB 12
Early research (Phase 1)Ended earlyNCT03370302
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies

Who this might be right for
Advanced Nonhematological Neoplasms
Calithera Biosciences, Inc 28
Large-scale testing (Phase 3)Study completedNCT00251680
What this trial is testing

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

Who this might be right for
Type 2 Diabetes
Takeda 400
Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136
Post-approval studies (Phase 4)Study completedNCT01630057
What this trial is testing

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Who this might be right for
Partial Seizures
Eisai Inc. 200
Next Page